Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion type Assertion NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_head.
- NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion description "[In vivo, ALK regulated VEGFA production and tumor angiogenesis in ALCL and NSCLC, and the treatment with the anti-VEGFA antibody bevacizumab strongly impaired ALCL growth in mouse xenografts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_provenance.
- NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion evidence source_evidence_literature NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_provenance.
- NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion SIO_000772 25193384 NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_provenance.
- NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion wasDerivedFrom befree-20150227 NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_provenance.
- NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_assertion wasGeneratedBy ECO_0000203 NP772646.RAU0mYwhINrDQb-S9cFVcFdZ6BaHRWsE87_ImnJGn6lvs130_provenance.